Affymax Research Institute entered the industry of Medical Research in 1988 and has grown to employ 1 to 4 people, generating an annual revenue of $5.000.000 to $9.999.999. The NAICS classifies this business under the code 541720, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Gordon Ringold Phd by calling (650) 812-8700 during business hours. You can also write to the business’ Single Location at 4001 Miranda Avenue, Palo Alto, California CA 94304. You can also visit the company’s website at investors.affymax.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Affymax Research Institute |
| Representative: | Gordon Ringold Phd |
| Place of Business: | 4001 Miranda Avenue, Palo Alto, CA 94304 |
| Contact Number: | (650) 812-8700 |
| Website: | investors.affymax.com |
| Type of Service: | Medical Research |
| SIC Number: | 8733 |
| NAICS Number: | 541720 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 1988 |
| Income/Year: | $5.000.000 to $9.999.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Affymax Research Institute is a company operating from Santa Clara, California providing professional Medical Research and relevant B2B variables. It was founded in 1988 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 541720 as Medical Research.
With a current employee count of 1 to 4, Affymax Research Institute has gone to report making $5.000.000 to $9.999.999 per annum on its journey towards growth. This company invites you to contact its representative Gordon Ringold Phd at (650) 812-8700 for related queries, or to locate its Single Location using the coordinates 37.402831,-122.141486.
The Single Location can also be found at the street address 4001 Miranda Avenue in Palo Alto, California 94304 and can be engaged online through the company website at investors.affymax.com, the company Twitter , and Facebook page .